Journal of Medical Economics
Volume 23, 2020 - Issue 12
Open access
3,929
Views
5
CrossRef citations to date
0
Altmetric
Hematology
A systematic review evaluating the efficacy and factor consumption of long-acting recombinant factor VIII products for the prophylactic treatment of hemophilia A
Lukas Grafa Zentrum für Labormedizin, Hämostase- und Hämophilie-Zentrum, St. Gallen, Switzerland
, Songkai Yanb Global Health Economics, CSL Behring, King of Prussia, PA, USACorrespondence[email protected]
, Ming-Ching Shenc Hemophilia Treatment and Thrombosis Center, Changhua Christian Hospital, Changhua, Taiwan
& Vinod Balasad Hematology/Oncology, Valley Children’s Healthcare and Hospital, Madera, CA, USA
Pages 1493-1498
|
Received 16 Jun 2020, Accepted 13 Sep 2020, Published online: 16 Oct 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.